Evidence map›Paper›PMID 32437056›Full record

ArticleCPT: pharmacometrics & systems pharmacology2020

Individualized Absorption Models in Population Pharmacokinetic Analyses.

Mutaz M Jaber, Mahmoud Al-Kofahi, Kyriakie Sarafoglou, Richard C Brundage

Abstract read
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mutaz M JaberDepartment of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.
Mahmoud Al-KofahiDepartment of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.
Kyriakie SarafoglouDepartment of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.
Richard C BrundageDepartment of Experimental and Clinical Pharmacology, University of Minnesota, Minneapolis, Minnesota, USA.

Funding

Ph2a SQ HC infusion pump in congenital adrenal hyperplasia IND125,640 (9/15/2017)R01FD006100 · FDA · UNIVERSITY OF MINNESOTA · PI BRUNDAGE, RICHARD C, SARAFOGLOU, KYRIAKIE · 2018 to 2021
$1.4M
FDA HHS R01 FD006100Office of Orphan Products Development of the US Food and Drug Administration R01FDR0006100
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gastrointestinal AbsorptionModels, BiologicalAdministration, OralAdrenal Hyperplasia, CongenitalHumansHydrocortisoneHydrocortisone

Identifiers

PMID32437056
PMCPMC7306615

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.